Rationale: We and others have demonstrated that anthocyanins have antiatherogenic capability. Because intact anthocyanins are absorbed very poorly, the low level of circulating parent anthocyanins may not fully account for their beneficial effect. We found recently that protocatechuic acid (PCA), a metabolite of cyanidin-3 to 0-β-glucoside (Cy-3-G), has a remarkable antiatherogenic effect. Objective: To investigate whether mouse gut microbiota metabolizes Cy-3-G into PCA and to determine whether and how PCA contributes to the antiatherogenic potency of its precursor, Cy-3-G. Methods and Results: PCA was determined as a gut microbiota metabolite of Cy-3-G in ApoE −/− mice, verified by the utilization of antibiotics to eliminate gut microbiota and further microbiota acquisition. PCA but not Cy-3-G at physiologically reachable concentrations promoted cholesterol efflux from macrophages and macrophage ABCA1 and ABCG1 expression. By conducting a miRNA microarray screening, we revealed that expression of miRNA-10b in macrophages can be reduced by PCA. Functional analyses demonstrated that miRNA-10b directly represses ABCA1 and ABCG1 and negatively regulates cholesterol efflux from murine- and human-derived macrophages. Further in vitro and ex vivo analyses verified that PCA accelerates macrophage cholesterol efflux, correlating with the regulation of miRNA-10b-ABCA1/ABCG1 cascade, whereas Cy-3-G consumption promoted macrophage RCT and regressed atherosclerotic lesion in a gut microbiotaendependent manner. Conclusions: PCA, as the gut microbiota metabolite of Cy-3-G, exerts the antiatherogenic effect partially through this newly defined miRNA-10b-ABCA1/ABCG1-cholesterol efflux signaling cascade. Thus, gut microbiota is a potential novel target for atherosclerosis prevention and treatment.

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Recently, functional applications of thermoplastic foams have received extensive attention from the research and materials communities, focusing on their various applications, key challenges, material systems designs, processing methods, and cellular structure characteristics needed for specific functional applications. This review paper starts with consideration of the microcellular foaming mechanism and basic concepts of microcellular foam processing, followed by polymer modification methods, and crucial factors that determine the performance of thermoplastic foams. Special emphasis has been placed on the synergies between foaming and reinforcements, including functional fillers and polymer blends; improvements in homogeneous, functional properties by achieving uniform cell structure and cell dispersion in polymer systems; and comparison of melt processing and solvent-based methods. Then, a wide array of advanced functional applications for foams-such as lightweight applications, heat and sound insulation, electromagnetic shielding, tissue engineering, oil spill cleanup, shape memory, and flexible materials-will be presented. In particular, the relationships between cellular structure and anticipated properties-including mechanical, barrier, dielectric, biomedical, and other properties required in advanced functional applications-will be discussed. Finally, we will outline a future perspective of lightweight and functional foams and suggest recommended future work regarding functional microcellular foams.

No abstract